< Back to previous page
Researcher
Wouter Peelaerts
- Disciplines:Microbiology, Systems biology, Biomaterials engineering, Biological system engineering, Biomechanical engineering, Other (bio)medical engineering, Environmental engineering and biotechnology, Industrial biotechnology, Other biotechnology, bio-engineering and biosystem engineering, Laboratory medicine
Affiliations
- Molecular Virology and Gene Therapy (Division)
Member
From1 Jan 2023 → Today - Research Group for Neurobiology and Gene Therapy (Division)
Member
From3 Oct 2011 → Today
Projects
1 - 10 of 10
- Urinary tract infections as a trigger of oligodendrogliopathy in multiple system atrophy.From1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- Elucidating the role of oligodendrocytes in humanised experimental models of synucleinopathy.From1 Sep 2023 → TodayFunding: BOF - projects
- Infectious disease triggers in humanized models of synucleinopathyFrom10 Jul 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Peripheral infections as a trigger of multiple system atrophyFrom1 Jan 2023 → TodayFunding: Other federal public and semi-governmental institutions
- Unique IsoPlexis technology for multiplexed single cell functional profilingFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- The role of viral infectious triggers in multiple system atrophyFrom19 Nov 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Peripheral disease triggers and disease progression in multiple system atrophyFrom1 Oct 2021 → 1 Jan 2024Funding: FWO senior postdoctoral fellowship
- Understanding the role of toxic alfa-synuclein protein aggregation as therapeutic target in synucleinopathy animal modelsFrom1 Oct 2017 → 31 Mar 2021Funding: FWO fellowships
- Investigating the role of human alpha-synuclein strains in synucleinopathiesFrom1 Jan 2017 → 15 Dec 2022Funding: FWO Strategic Basic Research Grant
- Study of intercellular transmission and neurotoxicity of alfa-synuclein in an animal model for Parkinson's disease using optogenetic neuromodulationFrom1 Oct 2011 → 28 Oct 2016Funding: FWO fellowships
Publications
1 - 10 of 18
- Urinary tract infections trigger synucleinopathy via the innate immune response(2023)
Authors: Wouter Peelaerts, Chris Van den Haute, Veerle Baekelandt
Pages: 541 - 559 - Host oligodendrogliopathy and α-synuclein strains dictate disease severity in multiple system atrophy(2023)
Authors: Veerle Baekelandt, Wouter Peelaerts
Pages: 237 - 251 - α-Synuclein Structural Diversity and the Cellular Environment in α-Synuclein Transmission Models and Humans(2023)
Authors: Wouter Peelaerts, Veerle Baekelandt
Pages: 67 - 82 - A historical review of multiple system atrophy with a critical appraisal of cellular and animal models(2021)
Authors: Wouter Peelaerts
Pages: 1507 - 1527 - Widespread, Specific, and Efficient Transgene Expression in Oligodendrocytes After Intracerebral and Intracerebroventricular Delivery of Viral Vectors in Rodent Brain(2021)
Authors: Wouter Peelaerts, Chris Van den Haute, Veerle Baekelandt
Pages: 616 - 627 - T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of alpha-Synuclein Fibrils(2021)
Authors: Wouter Peelaerts
Pages: 585 - 603 - The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson’s disease, multiple system atrophy and dementia with Lewy bodies(2020)
Authors: Géraldine Gelders, Wouter Peelaerts, Chris Van den Haute, Veerle Baekelandt
Pages: 977 - 1000 - Inhibiting the mitochondrial pyruvate carrier does not ameliorate synucleinopathy in the absence of inflammation or metabolic deficits.(2020)
Authors: Wouter Peelaerts
Pages: 33 - Can infections trigger alpha-synucleinopathies?(2019)
Authors: Wouter Peelaerts
Pages: 299 - 322 - Targeting energy metabolism via the mitochondrial pyruvate carrier as a novel approach to attenuate neurodegeneration(2018)
Authors: Wouter Peelaerts